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We detected Rickettsia felis DNA in Ctenocephalides
felis and Bartonella quintana DNA in 3 Pulex irritans fleas
taken from a pet Cercopithecus cephus monkey in Gabon,
sub-Saharan Africa. This is the first report of B. quintana in
the human flea.
B
artonellae are gram-negative bacteria that cause sever-
al human diseases and are transmitted by various
arthropods, such as lice, ticks, and fleas (1). Bartonella
quintana is a worldwide fastidious bacterium that infects
humans and belongs to the alpha subgroup of the
Proteobacteria. Recent reports suggest that humans are the
natural reservoir of B. quintana and that the human body
louse is the vector (1). However, we have recently report-
ed molecular detection of several Bartonella  species,
including B. quintana, in Ctenocephalides felis fleas from
France, which suggests that fleas may be important vectors
of human disease (2). Fleas are found worldwide on mam-
mals and are vectors of several major zoonoses, including
plague caused by Yersinia pestis (3), murine typhus caused
by Rickettsia typhi, and fleaborne spotted fever caused by
R. felis (3). More than 2,000 species of fleas exist world-
wide. While some species are highly host specific, others
are more catholic and will feed on numerous hosts, espe-
cially in the absence of their preferred host (3). Several flea
species, including Pulex irritans, C. canis,  C. felis,
Ceratophyllus gallinae, Ceratophyllus columbae, and
Archaeopsylla erinacei, may infest humans. In this study,
we collected P. irritans (human fleas) and C. felis fleas on
a pet monkey in Gabon and report for the first time the
molecular detection of B. quintana in P. irritans.
The Study 
Four fleas collected from a pet monkey (Cercopithecus
cephus) in Franceville, Gabon, were stored in 70% alcohol
and sent to the World Health Organization (WHO)
Collaborative Center for Rickettsial Reference and
Research in Marseille, France, where molecular studies
were performed in April 2005. Fleas were rinsed with dis-
tilled water for 10 min and dried on sterile filter paper in a
laminar flow hood. Preliminary entomologic identification
was performed by using reference taxonomic keys as pre-
viously reported (4).
Fleas were crushed individually in sterile Eppendorf
tubes with the tip of a sterile pipette. DNA was then
extracted by using the QIAamp Tissue Kit (Qiagen,
Hilden, Germany) according to manufacturer’s instruc-
tions. Rickettsial DNA was detected by polymerase chain
reaction (PCR) with primers targeting the citrate synthase
gene (gltA) as previously described (4). R. montanensis
DNA was used as positive control, and negative controls
consisted of laboratory uninfected flea DNA. Bartonella
DNAwas detected by PCR with 3 sets of primers targeting
the intergenic spacer (ITS) gene, and the B. quintana spac-
ers 336 and 894 as previously described (4,5). B. eliza-
bethae DNA was used as positive control and uninfected
fleas as negative controls. Additionally, fleas were identi-
fied at the species level after amplification and sequencing
of a portion of the 18S rDNAgene as previously described
(4). PCR products were purified, and DNAsequencing was
carried out by using the d-Rhodamine Terminator cycle
sequencing ready reaction kit with Amplitaq Polymerase
FS (Perkin-Elmer, Coignieres, France) as described by the
manufacturer. For all PCR products, sequences from both
DNAstrands were determined twice. Sequencing products
were resolved by using an ABI 3100 automated sequencer
(Perkin-Elmer). Sequence analysis was performed by
using the software package ABI Prism DNA Sequencing
Analysis Software version 3.0 (Perkin-Elmer). All
obtained sequences were compared with those available in
GenBank by using the nucleotide-nucleotide BLAST
(blastn) program (http://www.ncbi.nlm.nih.gov/BLAST/).
Using morphologic taxonomic keys, 3 fleas were iden-
tified as P. irritans and 1 flea as Ctenocephalides felis.
These findings were unambiguously confirmed when a
331-bp fragment of the 18S rDNAgene showed 99.7% and
99.4% homology with previous sequences of C. felis
(GenBank accession no. AF423914) and P. irritans
(GenBank accession no. AF423915). When gltA primers
were used, R.  felis (GenBank accession no. AF516333,
100% homology) was detected in the C. felis, whereas the
P. irritans as well as negative controls were negative.
Using the ITS primers for Bartonella spp., we detected
PCR products in the 3 P. irritans fleas, whereas the C. felis
flea and negative controls were negative. By sequencing
the ITS gene–amplified fragments from these 3 fleas, we
identified B. quintana (GenBank accession no. AF368396,
100% homology). Two PCR procedures targeting specific
B. quintana spacers previously described (5) were carried
out to confirm the results. By using these primers, B. quin-
tana type 1 sequence was obtained for the spacer 336
(GenBank accession no. AY660705, 100% homology) and
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France B. quintana type 2 sequence for the spacer 894 (GenBank
accession no. AY660713, 100% homology). Thus, accord-
ing to current guidelines for B. quintana typing (5), we
have amplified genotype 2 of B. quintana. 
Conclusions
We present here the first molecular detection of R. felis
in sub-Saharan Africa, Gabon (Figure). To date, 4 species
of fleas have been associated worldwide with R. felis
including C. felis (3,6), C. canis (6), P. irritans (3), and
Archeopsylla erinacei (4). Thus, the amplification of R.
felis in the C. felis flea from the monkey was not surpris-
ing but suggests that nonhuman primates may be infected
as well as humans and may represent a reservoir of R. felis.
The role of mammals, including rodents, hedgehogs, cats,
dogs, and monkeys, in the life cycle and circulation of R.
felis remains unclear and warrants further epidemiologic
studies. 
We report for the first time that the human flea P. irri-
tans can be infected with B. quintana. Apart from the body
louse, the natural vector of B. quintana in humans, we
have previously detected B. quintana in C. felis fleas with
a prevalence of 4.5% in a series of 309 fleas collected in
various regions of France (2). Thus, our results confirm
that B. quintana may be found in the human flea and may
explain 2 clinical reports of chronic adenopathy attributed
to B. quintana infection for which the only epidemiologic
risk factor identified was the presence of fleas (7,8). Few
reports of detection of other bartonellae in fleas have been
made (Table). Recently, the rodent flea Ctenophthalmus
nobilis has been found to be a competent vector of at least
2 Bartonella species, B. grahamii, which has previously
been associated with human infection, and B. taylorii (9).
In contrast, no evidence of either horizontal or vertical
transmission was seen in bank voles (Clethrionomys glare-
olus) injected with B. taylorii maintained in an arthropod-
free environment, which suggests that fleas may be
essential for transmitting some Bartonella spp. (9). In the
study of Stevenson et al, Bartonella spp. were detected in
38 Oropsylla hirsuta and 3 Oropsylla tuberculatus cyno-
muris prairie dog fleas in United States (10). In addition,
new Bartonella genotypes, whose medical importance is
not yet known, were detected in Pulex fleas in Peru (11),
in 5 C. felis collected from cats, and in a Nosopsyllus fas-
ciatus collected from a Rattus surifer specimen in Thailand
(6). 
Although detection of Bartonella DNA is often report-
ed from several sources, including fleas, mammals, and
human samples, isolation of bartonellae by culture remains
infrequent (12). Culture media and procedures used for
Bartonella spp. have been highly variable and have ques-
tionable sensitivity (12). A novel chemically modified liq-
uid medium that will support the growth of several
Bartonella spp. has been recently developed and may pro-
vide an advantage over conventional blood agar culture for
the isolation of Bartonella spp. (13). The prevalence of B.
quintana as well as other bartonellae in human fleas
remains unknown, and this subject needs to be addressed
to better define possible sources of Bartonella infections in
humans. 
Bartonella quintana and Rickettsia felis in Gabon
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Figure. Detection of Rickettsia felis in fleas worldwide. *This study.Acknowledgments
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